The Purpose of This Study is to Evaluate the Pharmacokinetic Properties of Intravitreal Ocriplasmin Prior to Planned Primary Pars Plana Vitrectomy (PPV)

NCT01159665 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Vitrectomy

Interventions

DRUG: ocriplasmin
DRUG: ocriplasmin
DRUG: ocriplasmin
DRUG: ocriplasmin
DRUG: ocriplasmin

Sponsor

ThromboGenics